Testing effectiveness (Phase 2)Study completedNCT01962103
What this trial is testing
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Who this might be right for
NeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more
Celgene 107